Unknown NA INTERVENTIONAL 2-arm NCT02168764

Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache

Sponsor: Autonomic Technologies, Inc.

Interventions ATI Neurostimulation System

Updated 9 times since 2017 Last updated: Jun 25, 2018 Started: Jul 31, 2014 Primary completion: Mar 31, 2019 Completion: Mar 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Chronic Cluster Headache, this trial is ongoing. The trial is conducted by Autonomic Technologies, Inc. and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jul 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Active Not Recruiting → Unknown Status

▶ Show 4 earlier versions

Jul 2018 — Jul 2020 [monthly]

Active Not Recruiting NA
Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting NA
Feb 2017 — Jun 2018 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Autonomic Technologies, Inc.

Data source: Autonomic Technologies, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amherst, United States , Ann Arbor, United States , Chicago, United States , Columbus, United States , Dallas, United States , Durham, United States , Falls Church, United States , Las Vegas, United States , Lebanon, United States , Los Angeles, United States and 12 more locations